683 Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Hold
40,000
0.76% 30
2026
Q1
$11.7M Sell
40,000
-2,000
-5% -$657K 0.61% 35
2025
Q4
$14.7M Buy
42,000
+24,000
+133% +$8.11M 0.64% 37
2025
Q3
$5.82M Sell
18,000
-7,000
-28% -$2.18M 0.3% 68
2025
Q2
$9.72M Sell
25,000
-2,000
-7% -$804K 0.64% 45
2025
Q1
$11.7M Buy
+27,000
New +$10.8M 0.81% 33

Other funds holding ELV

683 Capital Management's ELV Position: Q2 2026 in Review

683 Capital Management held its Elevance Health (ELV) position steady in Q2 2026 at 40,000 shares worth $15.5M. The position accounts for 0.76% of the portfolio, ranked #30.

683 Capital Management first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • 683 Capital Management held 40,000 shares of Elevance Health worth $15.5M as of Q2 2026.
  • 683 Capital Management left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.76% of 683 Capital Management's portfolio in Q2 2026, its #30 holding.
  • 683 Capital Management first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.